Effects of growth hormone therapy in prepubertal children with short stature secondary to intrauterine growth retardation. 1994

J L Chaussain, and M Colle, and F Landier
Department of Paediatrics, Hôpital St Vincent de Paul, Paris, France.

A total of 130 short children were included in a French multicentre study and randomized between a control group (group A) and two groups treated with daily subcutaneous injections of GH at doses of 0.7 IU/kg/week (group B) and 1.4 IU/kg/week (group C) for 2 years. Height velocity was significantly increased (p < 0.0005) in groups B and C, with a greater increase in group C than in group B (p < 0.001). The benefit after 2 years compared with controls was 4.3 cm in group B and 5.9 cm in group C. The rate of bone maturation was not affected by GH therapy. These results led to the conclusion that 2 years of treatment with GH improves final height prognosis in children with short stature secondary to IUGR, and that this effect is dose dependent. The effect on final height has still to be demonstrated.

UI MeSH Term Description Entries
D008297 Male Males
D001827 Body Height The distance from the sole to the crown of the head with body standing on a flat surface and fully extended. Body Heights,Height, Body,Heights, Body
D002113 Calcification, Physiologic Process by which organic tissue becomes hardened by the physiologic deposit of calcium salts. Bone Mineralization,Calcification, Physiological,Physiologic Calcification,Mineralization, Bone,Physiological Calcification
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005317 Fetal Growth Retardation Failure of a FETUS to attain expected GROWTH. Growth Retardation, Intrauterine,Intrauterine Growth Retardation,Fetal Growth Restriction,Intrauterine Growth Restriction
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

J L Chaussain, and M Colle, and F Landier
January 1998, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
J L Chaussain, and M Colle, and F Landier
January 1996, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
J L Chaussain, and M Colle, and F Landier
January 1997, Hormone research,
J L Chaussain, and M Colle, and F Landier
December 2000, Clinical endocrinology,
J L Chaussain, and M Colle, and F Landier
January 1998, Hormone research,
J L Chaussain, and M Colle, and F Landier
January 1998, Hormone research,
J L Chaussain, and M Colle, and F Landier
January 2002, Hormone research,
J L Chaussain, and M Colle, and F Landier
April 1998, The Journal of clinical endocrinology and metabolism,
J L Chaussain, and M Colle, and F Landier
March 2001, Journal of pediatric endocrinology & metabolism : JPEM,
Copied contents to your clipboard!